Cite
HARVARD Citation
Giordano, S. et al. (n.d.). Combined anti-MET/EGFR treatment results in complete tumor regression and prevents resistance onset in a MET-amplified gastroesophageal xenopatient cohort. European journal of cancer. pp. S196-. [Online].